Featured Research

from universities, journals, and other organizations

Emory University Researcher Studies Effects Of Temporal Lobectomy On Seizures

Date:
December 27, 2000
Source:
Emory University Health Sciences Center
Summary:
Anterior temporal lobectomy is effective surgery for certain types of seizures in patients with temporal lobe epilepsy, according to a study conducted by researchers at Emory University.

Anterior temporal lobectomy is effective surgery for certain types of seizures in patients with temporal lobe epilepsy, according to a study conducted by researchers at Emory University. The study is published in the December 26 issue of the journal, Neurology. "While temporal lobe epilepsy (TLE) is the single most common type of epilepsy, only about half of patients fully control their seizures with medications," said Thomas R. Henry, M.D., principal investigator, director of the Emory Epilepsy Center and associate professor of neurology at the Emory University School of Medicine. "In patients with epilepsy, a network of brain cells, which is distributed over widespread brain systems, must participate in starting and stopping seizures. Our study finds that in patients with TLE, the network of brain cells that generate complex partial seizures, or psychomotor seizures, are at least partly separate from the networks that produce generalized tonic-clonic seizures, commonly known as grand mal seizures. We found that temporal lobectomy is highly effective in stopping complex partial seizures among patients who have seizures that cannot be controlled by medication, but is clearly less effective in stopping generalized tonic-clonic seizures in the same patients."

Dr. Henry and his team of investigators studied 60 patients who had temporal lobectomies performed at the University of Michigan between March 1991 and March 1994 and who had seizure records available for at least two years prior to surgery and two years after surgery. They discovered that the total number of seizures (both complex partial and grand mal seizures) experienced by these patients after surgery was significantly lower than the total number they experienced before surgery, although the fraction of grand mal seizures was significantly higher post-operatively.

"Most patients experienced no seizures at all after surgery," Dr. Henry noted. "However, those who did were more likely to experience grand mal seizures."

It's common in complex partial seizures for patients to lose consciousness for less than a minute, but typically do not fall or have jerking of the entire body. During a grand mal seizure, the patient usually falls and is unconscious. The entire body becomes tense and jerks uncontrollably. Breathing may stop briefly. The person usually has no memory of the event upon regaining consciousness, and may have headaches or feel a need to sleep. "This study provides a lot of information about epilepsy surgery that hadn't been discovered in the past," Dr. Henry said.

Dr. Henry conducted his research with Ivo Drury, MBBCh and Lori Schuh, M.D., both from the department of neurology at Henry Ford Hospital in Detroit, and Donald Ross, M.D., from the section of neurosurgery at the University of Michigan.

The Emory Epilepsy Center was established in 1994 and is a comprehensive effort among Emory neurologists, neurosurgeons, neuropsychologists, radiologists, researchers and nurses to offer adults and children with epilepsy access to the most advanced diagnostic, medication and surgical options.


Story Source:

The above story is based on materials provided by Emory University Health Sciences Center. Note: Materials may be edited for content and length.


Cite This Page:

Emory University Health Sciences Center. "Emory University Researcher Studies Effects Of Temporal Lobectomy On Seizures." ScienceDaily. ScienceDaily, 27 December 2000. <www.sciencedaily.com/releases/2000/12/001227082254.htm>.
Emory University Health Sciences Center. (2000, December 27). Emory University Researcher Studies Effects Of Temporal Lobectomy On Seizures. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2000/12/001227082254.htm
Emory University Health Sciences Center. "Emory University Researcher Studies Effects Of Temporal Lobectomy On Seizures." ScienceDaily. www.sciencedaily.com/releases/2000/12/001227082254.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins